| Number of cases(%) |
---|---|
Serum MOG-Ab titer (n = 30, range = 1:10‒1000) | |
 ≤ 1:32 | 13 (43.3) |
 ≥ 1:100 to < 1:320 | 10 (33.3) |
 ≥ 1:320 | 7 (23.3) |
CSF MOG-Ab titer (n = 9, range = 1:1‒10) | |
 ≥ 1:1 to < 1:3.2 | 3 (37.5) |
 ≥ 1:3.2 to < 1:10 | 2 (25.0) |
 ≥ 1:10 | 3 (37.5) |
Serum MOG-Ab titer prognosis | |
 Became negative | 11 (36.7) |
 Decreased | 4 (13.3) |
 Maintained | 2 (6.7) |
 Increased, then decreased | 3 (10.0) |
 Became negative, then relapsed | 4 (13.3) |
 Became negative, then relapsed, then became negative | 1 (3.3) |
 Became negative, then relapsed, then decreased | 2 (6.7) |
 Decreased, and then increased | 2 (6.7) |
 Decreased, then increased, then decreased | 1 (3.3) |